WO2012088330A3 - Devices, systems, and methods for fecal analysis - Google Patents

Devices, systems, and methods for fecal analysis Download PDF

Info

Publication number
WO2012088330A3
WO2012088330A3 PCT/US2011/066616 US2011066616W WO2012088330A3 WO 2012088330 A3 WO2012088330 A3 WO 2012088330A3 US 2011066616 W US2011066616 W US 2011066616W WO 2012088330 A3 WO2012088330 A3 WO 2012088330A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
devices
systems
body fluids
analysis
Prior art date
Application number
PCT/US2011/066616
Other languages
French (fr)
Other versions
WO2012088330A2 (en
Inventor
Rakesh Vig
Richard H. Selinfreund
Richard P. Gill
Original Assignee
Companion Diagnostics Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Companion Diagnostics Inc. filed Critical Companion Diagnostics Inc.
Publication of WO2012088330A2 publication Critical patent/WO2012088330A2/en
Publication of WO2012088330A3 publication Critical patent/WO2012088330A3/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57419—Specifically defined cancers of colon

Abstract

Herein are presented devices, systems, and methods for biomarker stabilization and analysis, including formulations which function to preserve the level of markers in body fluids from enzymatic alteration and degradation. In embodiments the methods and formulations disclosed can be used to improve the sampling and testing of a body fluid (including body fluids comprising fecal matter) by conditioning the body fluid. Also provided are embodiments of devices for detecting and indicating diagnostic markers in body fluids as well as the diagnosis of particular disease states.
PCT/US2011/066616 2010-12-22 2011-12-21 Devices, systems, and methods for fecal analysis WO2012088330A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201061425784P 2010-12-22 2010-12-22
US61/425,784 2010-12-22

Publications (2)

Publication Number Publication Date
WO2012088330A2 WO2012088330A2 (en) 2012-06-28
WO2012088330A3 true WO2012088330A3 (en) 2012-09-13

Family

ID=46314904

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2011/066616 WO2012088330A2 (en) 2010-12-22 2011-12-21 Devices, systems, and methods for fecal analysis

Country Status (1)

Country Link
WO (1) WO2012088330A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11458476B2 (en) 2019-10-17 2022-10-04 Marvin Liu In-situ fecal specimen sampling device

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5066463A (en) * 1990-10-01 1991-11-19 Chang Maw Guay Multiple-purpose fecal examination apparatus
US20050069900A1 (en) * 2003-09-25 2005-03-31 Cytyc Corporation Analyte sample detection
US20050232813A1 (en) * 2004-04-16 2005-10-20 Karmali Rashida A Specimen collecting, processing and analytical assembly
US20070172823A1 (en) * 2003-09-23 2007-07-26 Universitaet Potsdam Method for conducting non-invasive early detection of colon cancer and/or of colon cancer precursor cells
US20070248989A1 (en) * 2006-04-21 2007-10-25 Prasad Devarajan Method and Kit for the Early Detection of Impaired Renal Status

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5066463A (en) * 1990-10-01 1991-11-19 Chang Maw Guay Multiple-purpose fecal examination apparatus
US20070172823A1 (en) * 2003-09-23 2007-07-26 Universitaet Potsdam Method for conducting non-invasive early detection of colon cancer and/or of colon cancer precursor cells
US20050069900A1 (en) * 2003-09-25 2005-03-31 Cytyc Corporation Analyte sample detection
US20050232813A1 (en) * 2004-04-16 2005-10-20 Karmali Rashida A Specimen collecting, processing and analytical assembly
US20070248989A1 (en) * 2006-04-21 2007-10-25 Prasad Devarajan Method and Kit for the Early Detection of Impaired Renal Status

Also Published As

Publication number Publication date
WO2012088330A2 (en) 2012-06-28

Similar Documents

Publication Publication Date Title
WO2012012693A3 (en) Methods for detecting signatures of disease or conditions in bodily fluids
WO2009025852A3 (en) Methods of using mirna for detection of in vivo cell death
WO2012054638A3 (en) Nmr systems and methods for the detection of analytes
WO2013039477A8 (en) Non-invasive methods of detecting target molecules
WO2012021795A3 (en) Pancreatic cancer biomarkers and uses thereof
WO2011008349A3 (en) Methods of identifying infectious disease and assays for identifying infectious disease
WO2009085234A3 (en) Use of micro-rna as a biomarker of immunomodulatory drug activity
WO2012100235A3 (en) Systems and methods for sample use maximization
WO2011015602A3 (en) Lung cancer biomarkers
WO2011142827A3 (en) Diagnostic markers for neuropsychiatric disease
WO2010103388A8 (en) Methods using axl as a biomarker of epithelial-to-mesnchymal transition
EP4060048A3 (en) Non-invasive diagnostic method for diagnosing bladder cancer
MY175351A (en) Method and kit for measurement of nk cell activity
WO2008027098A3 (en) Biosensor for measurement of species in a body fluid
WO2012012704A3 (en) Methods of detecting kidney-associated diseases or conditions
WO2011156734A3 (en) Method of characterizing vascular diseases
WO2010097186A8 (en) Use of s-erbb-3 as a marker for cancer
NZ608316A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2012006056A3 (en) Ccr6 as a biomarker of alzheimer's disease
BR112014031957A2 (en) bag3 as biochemical serum and tissue marker
BR112013016071A2 (en) "Methods, device and diagnostic kit for diabetes and use of glyoxylate or a glyoxylate detection agent"
WO2011074802A3 (en) Kit for diagnosing prostate cancer and diagnosis method
WO2010136163A8 (en) Secernin-1 as a marker for cancer
WO2014087255A3 (en) Systems and methods for monitoring biological fluids
WO2013009146A3 (en) Marker for diagnosing diabetic retinopathy

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11851897

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11851897

Country of ref document: EP

Kind code of ref document: A2